No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

ulrich medical USA® Announces the Nationwide Commercial Release of the Momentum Posterior Spinal Fixation System

Editor: What To Know

  • , a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States announced the nationwide commercial release of the Momentum Posterior Spinal Fixation System.
  • All screws for the Momentum System are offered in a range of lengths, diameters, and angulations to accommodate unique patient anatomy.
  • Louis, Missouri, the new Momentum rod-screw system includes polyaxial, reduction, and iliac screws, and is compatible with ulrich medical USA’s neon3® Universal OCT Spinal Stabilization System via transition rods and connectors.

July 14, 2020

ulrich medical USA, Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States announced the nationwide commercial release of the Momentum Posterior Spinal Fixation System.

Ulrich Medical USA Chief Commercial Officer Erika Strecker-Laskey said, “After completing hundreds of procedures during the alpha launch, Momentum has already made its mark with an enthusiastic reception and positive reviews from our alpha surgeon users.” She added, “Even amid the healthcare challenges presented by the Covid-19 crisis, we have seen steadily-increasing use of Momentum during this time and a growing demand for more sets.”

Dr. Christopher F. Wagener of Allentown, PA performed multiple procedures with Momentum during the alpha launch period and said, “Momentum gives surgeons exactly what they need, both simplicity and reliability.”

Developed in St. Louis, Missouri, the new Momentum rod-screw system includes polyaxial, reduction, and iliac screws, and is compatible with ulrich medical USA’s neon3® Universal OCT Spinal Stabilization System via transition rods and connectors. This offering allows for surgical constructs capable of bridging from the sacroiliac to the cervical spine.

All screws for the Momentum System are offered in a range of lengths, diameters, and angulations to accommodate unique patient anatomy. Screws are available from Ø 4.5mm to Ø 10.0mm, and in lengths from 25mm to 110mm. The system also offers both titanium and cobalt chrome rods (curved and straight) in Ø 5.5mm and Ø 6.0mm diameters. Single-use drills and taps guarantee consistent instrument performance for optimized clinical results. In addition, specialty surgical instrument modules are available for iliac fixation and deformity (basic) applications.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy